The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is confident of India’s pharmaceutical industry’s growth opportunities and is looking to continue strengthening its relationship with other countries for export, by preparing to participate at Arab Health 2013.
Representing Pharmexcil at Arab Health 2013 Dr PV Appaji, Director General, Pharmaceuticals Export Promotions Council of India, said, “Amid global economic concerns, the Indian pharmaceutical industry is bullish with a steep growth target. Within the pharmal sector, India is one of the top five generic exporters of the world and maintains a positive trade balance. This is the seventh year for the council to take part at the prestigious Arab Health event. Indian companies are very aware of the market potential in the Middle East and they will showcase a unique variety of high-tech and innovative products, aiming to expand their business in the Middle East region.”
Arab Health Exhibition & Congress is the second largest healthcare event in the world, the largest in the Middle East. Established 38 years ago, Arab Health provides a platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and subcontinent. Arab Health, organised by Informa Life Sciences Exhibitions, takes place from January 28-31, 2013 at the Dubai International Convention and Exhibition Centre. With more than 3500 exhibiting companies from 32 countries, and 18 CME accredited medical conferences, Arab Health is a much anticipated addition to the 2013 medical event calendar in the Middle East and subcontinent region.
Indian firms manufactured products for nearly 60,000 generic brands, covering 60 key therapeutic areas. Approximately 80 per cent of this domestic production consisted of formulations, while the remaining 20 per cent comprised bulk drugs. India accounts for almost 10 per cent of global drug production by volume and is increasingly focusing on indigenous R&D. There are about 3000 pharma manufacturers, with over 10500 units, the vast majority of which focus on generic drugs. Companies such as Ascent Healthcare, Adroit Manufacturing Co, Dr. Surgicals, Lab Care Diagnostics (I) PVT LTD, and approx. 70 other healthcare and pharmaceutical companies from India will be exhibiting at Arab Health this year.
Arab Health 2013 is one of the major International exhibitions for surgical, hospital, medical equipment and pharmaceuticals. It offers important opportunities to build relations within the industry, to showcase progress and achievement in the field and to explore new opportunities with stakeholders in the healthcare field. This year more than 200 new exhibitors will bring the total to almost 3500 from 63 countries across the globe.
The trade show is followed by The Arab Heath Innovation & Achievement Awards which continues to draw hundreds of nominations from healthcare facilities and individuals across the region. The 2013 Arab Health Awards ceremony will take place on January 29 in Dubai, UAE
EP News Bureau – Mumbai
- Advertisement -
